Doğan Şensoy
Research Subjects
Research Interests
Doğan Şensoy has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Güven Kılıç
Faculty of Medicine, Department of Neurosurgery, Düzce University, Düzce, Turkey
2 shared publications - Ömer Polat
Bolu Çağsu Hastanesi
2 shared publications - Hakan Soylu
Düzce University, Faculty of Medicine, Department of Histology and Embryology, Düzce, Türkiye
1 shared publication - Kayihan Karacor
Düzce University
1 shared publication - Muammer Yakupoğlu
Dr. Nevruz Erez Devlet Hastanesi
1 shared publication
Latest Publications
- Open Access
- 30 December 2024
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 26 (3) , 248-254
Clinical and Histopathological Effects of Isotretinoin on Neuroregeneration in Experimental Spinal Cord Injury
Aim: Spinal cord injury is an important problem, and a fully effective treatment for it has not yet been developed. Isotretinoin is a retinoid known for its anti-inflammatory effect. The present study aimed to evaluate whether isotretinoin has a positive impact on neural tissue in post-injury damage. Material and Methods: A total of 36 rats were randomly divided into 6 groups as control, sham, and injury with 14-day 7.5 mg/kg/day, 28-day 7.5 mg/kg/day, 14-day 15 mg/kg/day, and 28-day 15 mg/kg/day isotretinoin groups. Laminectomy was performed and spinal cord injury was produced by using the clip compression technique. Neurological examination was performed on days 1, 7, 14, and 28. After the treatment period, all rats were sacrificed, and their spinal cord samples were collected for histopathological assessment. Results: Groups receiving 7.5 mg/kg/day (p=0.048) and 15 mg/kg/day (p
- 30 December 2024
- Published by Duzce Medical Journal in Düzce Tıp Fakültesi Dergisi
- Vol. 26 (3) , 248-254
Open AccessClinical and Histopathological Effects of Isotretinoin on Neuroregeneration in Experimental Spinal Cord Injury
Aim: Spinal cord injury is an important problem, and a fully effective treatment for it has not yet been developed. Isotretinoin is a retinoid known for its anti-inflammatory effect. The present study aimed to evaluate whether isotretinoin has a positive impact on neural tissue in post-injury damage. Material and Methods: A total of 36 rats were randomly divided into 6 groups as control, sham, and injury with 14-day 7.5 mg/kg/day, 28-day 7.5 mg/kg/day, 14-day 15 mg/kg/day, and 28-day 15 mg/kg/day isotretinoin groups. Laminectomy was performed and spinal cord injury was produced by using the clip compression technique. Neurological examination was performed on days 1, 7, 14, and 28. After the treatment period, all rats were sacrificed, and their spinal cord samples were collected for histopathological assessment. Results: Groups receiving 7.5 mg/kg/day (p=0.048) and 15 mg/kg/day (p
- Open Access
- 4 January 2023
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 57 (4) , 127-133
Effects of isotretinoin and acitretin on neuroregeneration in experimental spinal cord injury
Objective: This study aimed to determine whether isotretinoin and acitretin have beneficial effects on neural tissue damage following acute spinal cord injury. Methods: Thirty-six rats were randomly divided into 6 groups: control, sham spinal cord injury, spinal cord injury with isotretinoin 15 mg/kg for 14 days, spinal cord injury with isotretinoin 15 mg/kg for 28 days, spinal cord injury with acitretin 10 mg/kg for 14 days, and spinal cord injury with acitretin 10 mg/kg for 28 days. The damage to the spinal cord was formed by the clip compression technique. A neurological evaluation was conducted on days 1, 14, and 28. All rats were sacrificed following the treatment period, and samples of their spinal cords were collected for histopathological analysis. Results: The inclined plane angle was significantly increased on the 14th and 28th days in the isotretinoin 15 mg and acitretin 10 mg groups, compared to the spinal injury group (P=.049 and P=.009, respectively). The Drummond–Moore criterion was significantly higher in the acitretin 10 mg group than in the injury group (P=.026). Cleaved Caspase-3 expression was similar in the isotretinoin 15 mg day 28 group and the control group (P > .05), but significantly decreased in the acitretin 10 mg 14th-day and acitretin 10 mg 28th-day groups compared to spinal injury isotretinoin 15 mg 14th-day and isotretinoin 15 mg 28th-day groups (P < .05). Conclusion: This was the first study elaborating that isotretinoin and acitretin reduced neuronal apoptosis and improved functional recovery after spinal cord injury. These neuroprotective effects might open a window of opportunity for patients. Cite this article as: Kılıç G, Polat Ö, Şensoy D, Soylu H. Effects of isotretinoin and acitretin on neuroregeneration in experimental spinal cord injury. Acta Orthop Traumatol Turc., 2023;57(4):127-133.
- 4 January 2023
- Published by AVES YAYINCILIK A.Ş. in Acta Orthopaedica et Traumatologica Turcica
- Vol. 57 (4) , 127-133
Open AccessEffects of isotretinoin and acitretin on neuroregeneration in experimental spinal cord injury
Objective: This study aimed to determine whether isotretinoin and acitretin have beneficial effects on neural tissue damage following acute spinal cord injury. Methods: Thirty-six rats were randomly divided into 6 groups: control, sham spinal cord injury, spinal cord injury with isotretinoin 15 mg/kg for 14 days, spinal cord injury with isotretinoin 15 mg/kg for 28 days, spinal cord injury with acitretin 10 mg/kg for 14 days, and spinal cord injury with acitretin 10 mg/kg for 28 days. The damage to the spinal cord was formed by the clip compression technique. A neurological evaluation was conducted on days 1, 14, and 28. All rats were sacrificed following the treatment period, and samples of their spinal cords were collected for histopathological analysis. Results: The inclined plane angle was significantly increased on the 14th and 28th days in the isotretinoin 15 mg and acitretin 10 mg groups, compared to the spinal injury group (P=.049 and P=.009, respectively). The Drummond–Moore criterion was significantly higher in the acitretin 10 mg group than in the injury group (P=.026). Cleaved Caspase-3 expression was similar in the isotretinoin 15 mg day 28 group and the control group (P > .05), but significantly decreased in the acitretin 10 mg 14th-day and acitretin 10 mg 28th-day groups compared to spinal injury isotretinoin 15 mg 14th-day and isotretinoin 15 mg 28th-day groups (P < .05). Conclusion: This was the first study elaborating that isotretinoin and acitretin reduced neuronal apoptosis and improved functional recovery after spinal cord injury. These neuroprotective effects might open a window of opportunity for patients. Cite this article as: Kılıç G, Polat Ö, Şensoy D, Soylu H. Effects of isotretinoin and acitretin on neuroregeneration in experimental spinal cord injury. Acta Orthop Traumatol Turc., 2023;57(4):127-133.